Troels Bo Thomsen

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The ability to harness the RNA interference (RNAi) mechanism as a potential potent therapeutic has attracted great interest from academia and industry. Numerous preclinical and recent clinical trials have demonstrated the effectiveness of RNAi triggers such as synthetic small interfering RNA (siRNA). Chemical modification and delivery technologies can be(More)
  • 1